Strength Profile of Hip Joint in Females With Primary Dysmenorrhea During Menstrual Cycle

Cairo University (CU)

Status

Completed

Conditions

Primary Dysmenorrhea

Treatments

Other: Assess Hip joint strength by Biodex isokinetic dynamometer (System 4 Pro)

Study type

Observational

Funder types

Other

Identifiers

NCT06615037

P.T.REC\012\005318

Details and patient eligibility

About

The goal of this observational study is to investigate the effect of primary dysmenorrhea on strength of hip joint muscles in females.

Full description

The menstrual cycle is a physiological process in females manifested as periodic vaginal bleeding due to the shedding of the uterine lining (menstruation). Characterized by dynamic fluctuations in serum concentrations of several female sex steroid hormones. Estrogen, progesterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) play a critical role in regulating the precise timing and events of the ovulatory cycle. Dysmenorrhea is considered a menstrual disorder and defined as painful menstrual cramps of uterine origin. It is classified as either primary or secondary dysmenorrhea (SD). Primary dysmenorrhea (PD) constitutes a prevalent gynecological condition in the absence of any identifiable pelvic pathology, characterized by cramping and severe pain localized within the lower abdomen. The prevalence of primary dysmenorrhea in females of reproductive age ranges from 45.0% to 94.0% in countries worldwide with 2% to 29% experiencing severe pain. A greater prevalence (70% to 90%) was generally reported among younger women (&lt;24 years). Moderate and severe dysmenorrhea has even become a major reason for absenteeism from academic and professional settings and physical activity limitation in young women. Physical activity from standing, walking and balance to high impact sports was found to be directly influenced by the strength, power, and endurance of lower limb (LL) muscles especially hip muscles. Previous studies showed that the strength of LL muscles is influenced by the hormonal fluctuation that occurs during menstrual cycle phases.

These trial participants; will be divided into two groups:

(Group A): Female with symptomatic PD according to WaLLID scale. (Group B): Female with asymptomatic PD according to WaLLID scale.

Enrollment

40 patients

Sex

Female

Ages

20 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age range from 20 to 25 years.
BMI ranges from 20 to 25 kg/m2.
Having a regular menstrual cycle (28 ± 7 days with no intermittent bleeding).
No pathology related to the pelvis.
Having no injury in the lower limb.
Not consuming contraceptives, dietary supplements and steroid drugs.

Exclusion criteria

Menstrual irregularity.
Pregnancy or suspicion of pregnancy.
Having given birth.
Using an intrauterine device.
Oral contraceptives or antidepressant use.
Having a diagnosis of secondary dysmenorrhea.
Surgical history involving the abdominal region, pelvic region, and/or the spine in the last year.
Having musculoskeletal problems related to lower extremities.
Having any psychiatric or gynecological problems.
Suffering from premenstrual syndrome.